[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Humira Market Insights, Forecast to 2026

June 2020 | 112 pages | ID: G50A68B3ACAAEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion in 2017 is about 43%, and the proportion is in decreasing trend from 2013 to 2017.
USA is the largest market, with a sales market share nearly 65% in 2017. Following USA, Europe is the second largest market with the sales market share of 30%.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Humira 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Humira 3900 industry.
Based on our recent survey, we have several different scenarios about the Humira 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 12050 million in 2019. The market size of Humira 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Humira market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Humira market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Humira market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Humira market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Humira market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Humira market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Humira market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Humira market.
The following manufacturers are covered in this report:
  • AbbVie
  • Eisai
  • Cadila Healthcare
  • Torrent Pharmaceuticals
  • Amgen
  • Boehringer Ingelheim
  • ...
Humira Breakdown Data by Type
  • Humira Syringe
  • Humira Pen
Humira Breakdown Data by Application
  • Ankylosing Spondylitis
  • Rheumatoid Arthritis
  • Crohn’s Disease
  • Other
1 STUDY COVERAGE

1.1 Humira Product Introduction
1.2 Market Segments
1.3 Key Humira Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Humira Market Size Growth Rate by Type
  1.4.2 Humira Syringe
  1.4.3 Humira Pen
1.5 Market by Application
  1.5.1 Global Humira Market Size Growth Rate by Application
  1.5.2 Ankylosing Spondylitis
  1.5.3 Rheumatoid Arthritis
  1.5.4 Crohn’s Disease
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Humira Industry Impact
  1.6.1 How the Covid-19 is Affecting the Humira Industry
    1.6.1.1 Humira Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Humira Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Humira Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Humira Market Size Estimates and Forecasts
  2.1.1 Global Humira Revenue 2015-2026
  2.1.2 Global Humira Sales 2015-2026
2.2 Humira Market Size by Region: 2020 Versus 2026
  2.2.1 Global Humira Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Humira Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL HUMIRA COMPETITOR LANDSCAPE BY PLAYERS

3.1 Humira Sales by Manufacturers
  3.1.1 Humira Sales by Manufacturers (2015-2020)
  3.1.2 Humira Sales Market Share by Manufacturers (2015-2020)
3.2 Humira Revenue by Manufacturers
  3.2.1 Humira Revenue by Manufacturers (2015-2020)
  3.2.2 Humira Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Humira Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Humira Revenue in 2019
  3.2.5 Global Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Humira Price by Manufacturers
3.4 Humira Manufacturing Base Distribution, Product Types
  3.4.1 Humira Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Humira Product Type
  3.4.3 Date of International Manufacturers Enter into Humira Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Humira Market Size by Type (2015-2020)
  4.1.1 Global Humira Sales by Type (2015-2020)
  4.1.2 Global Humira Revenue by Type (2015-2020)
  4.1.3 Humira Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Humira Market Size Forecast by Type (2021-2026)
  4.2.1 Global Humira Sales Forecast by Type (2021-2026)
  4.2.2 Global Humira Revenue Forecast by Type (2021-2026)
  4.2.3 Humira Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Humira Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Humira Market Size by Application (2015-2020)
  5.1.1 Global Humira Sales by Application (2015-2020)
  5.1.2 Global Humira Revenue by Application (2015-2020)
  5.1.3 Humira Price by Application (2015-2020)
5.2 Humira Market Size Forecast by Application (2021-2026)
  5.2.1 Global Humira Sales Forecast by Application (2021-2026)
  5.2.2 Global Humira Revenue Forecast by Application (2021-2026)
  5.2.3 Global Humira Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Humira by Country
  6.1.1 North America Humira Sales by Country
  6.1.2 North America Humira Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Humira Market Facts & Figures by Type
6.3 North America Humira Market Facts & Figures by Application

7 EUROPE

7.1 Europe Humira by Country
  7.1.1 Europe Humira Sales by Country
  7.1.2 Europe Humira Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Humira Market Facts & Figures by Type
7.3 Europe Humira Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Humira by Region
  8.1.1 Asia Pacific Humira Sales by Region
  8.1.2 Asia Pacific Humira Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Humira Market Facts & Figures by Type
8.3 Asia Pacific Humira Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Humira by Country
  9.1.1 Latin America Humira Sales by Country
  9.1.2 Latin America Humira Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Humira Market Facts & Figures by Type
9.3 Central & South America Humira Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Humira by Country
  10.1.1 Middle East and Africa Humira Sales by Country
  10.1.2 Middle East and Africa Humira Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 UAE
10.2 Middle East and Africa Humira Market Facts & Figures by Type
10.3 Middle East and Africa Humira Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 AbbVie
  11.1.1 AbbVie Corporation Information
  11.1.2 AbbVie Description, Business Overview and Total Revenue
  11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 AbbVie Humira Products Offered
  11.1.5 AbbVie Recent Development
11.2 Eisai
  11.2.1 Eisai Corporation Information
  11.2.2 Eisai Description, Business Overview and Total Revenue
  11.2.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Eisai Humira Products Offered
  11.2.5 Eisai Recent Development
11.3 Cadila Healthcare
  11.3.1 Cadila Healthcare Corporation Information
  11.3.2 Cadila Healthcare Description, Business Overview and Total Revenue
  11.3.3 Cadila Healthcare Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Cadila Healthcare Humira Products Offered
  11.3.5 Cadila Healthcare Recent Development
11.4 Torrent Pharmaceuticals
  11.4.1 Torrent Pharmaceuticals Corporation Information
  11.4.2 Torrent Pharmaceuticals Description, Business Overview and Total Revenue
  11.4.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Torrent Pharmaceuticals Humira Products Offered
  11.4.5 Torrent Pharmaceuticals Recent Development
11.5 Amgen
  11.5.1 Amgen Corporation Information
  11.5.2 Amgen Description, Business Overview and Total Revenue
  11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Amgen Humira Products Offered
  11.5.5 Amgen Recent Development
11.6 Boehringer Ingelheim
  11.6.1 Boehringer Ingelheim Corporation Information
  11.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
  11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Boehringer Ingelheim Humira Products Offered
  11.6.5 Boehringer Ingelheim Recent Development
11.1 AbbVie
  11.1.1 AbbVie Corporation Information
  11.1.2 AbbVie Description, Business Overview and Total Revenue
  11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 AbbVie Humira Products Offered
  11.1.5 AbbVie Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Humira Market Estimates and Projections by Region
  12.1.1 Global Humira Sales Forecast by Regions 2021-2026
  12.1.2 Global Humira Revenue Forecast by Regions 2021-2026
12.2 North America Humira Market Size Forecast (2021-2026)
  12.2.1 North America: Humira Sales Forecast (2021-2026)
  12.2.2 North America: Humira Revenue Forecast (2021-2026)
  12.2.3 North America: Humira Market Size Forecast by Country (2021-2026)
12.3 Europe Humira Market Size Forecast (2021-2026)
  12.3.1 Europe: Humira Sales Forecast (2021-2026)
  12.3.2 Europe: Humira Revenue Forecast (2021-2026)
  12.3.3 Europe: Humira Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Humira Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Humira Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Humira Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Humira Market Size Forecast by Region (2021-2026)
12.5 Latin America Humira Market Size Forecast (2021-2026)
  12.5.1 Latin America: Humira Sales Forecast (2021-2026)
  12.5.2 Latin America: Humira Revenue Forecast (2021-2026)
  12.5.3 Latin America: Humira Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Humira Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Humira Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Humira Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Humira Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Humira Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Humira Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details

LIST OF TABLES

Table 1. Humira Market Segments
Table 2. Ranking of Global Top Humira Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Humira Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Humira Syringe
Table 5. Major Manufacturers of Humira Pen
Table 6. COVID-19 Impact Global Market: (Four Humira Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Humira Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Humira Players to Combat Covid-19 Impact
Table 11. Global Humira Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Humira Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Humira Sales by Regions 2015-2020 (K Units)
Table 14. Global Humira Sales Market Share by Regions (2015-2020)
Table 15. Global Humira Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Humira Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Humira Sales Share by Manufacturers (2015-2020)
Table 18. Global Humira Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Humira by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Humira as of 2019)
Table 20. Humira Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Humira Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Humira Price (2015-2020) (USD/Unit)
Table 23. Humira Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Humira Product Type
Table 25. Date of International Manufacturers Enter into Humira Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Humira Sales by Type (2015-2020) (K Units)
Table 28. Global Humira Sales Share by Type (2015-2020)
Table 29. Global Humira Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Humira Revenue Share by Type (2015-2020)
Table 31. Humira Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Humira Sales by Application (2015-2020) (K Units)
Table 33. Global Humira Sales Share by Application (2015-2020)
Table 34. North America Humira Sales by Country (2015-2020) (K Units)
Table 35. North America Humira Sales Market Share by Country (2015-2020)
Table 36. North America Humira Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Humira Revenue Market Share by Country (2015-2020)
Table 38. North America Humira Sales by Type (2015-2020) (K Units)
Table 39. North America Humira Sales Market Share by Type (2015-2020)
Table 40. North America Humira Sales by Application (2015-2020) (K Units)
Table 41. North America Humira Sales Market Share by Application (2015-2020)
Table 42. Europe Humira Sales by Country (2015-2020) (K Units)
Table 43. Europe Humira Sales Market Share by Country (2015-2020)
Table 44. Europe Humira Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Humira Revenue Market Share by Country (2015-2020)
Table 46. Europe Humira Sales by Type (2015-2020) (K Units)
Table 47. Europe Humira Sales Market Share by Type (2015-2020)
Table 48. Europe Humira Sales by Application (2015-2020) (K Units)
Table 49. Europe Humira Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Humira Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Humira Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Humira Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Humira Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Humira Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Humira Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Humira Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Humira Sales Market Share by Application (2015-2020)
Table 58. Latin America Humira Sales by Country (2015-2020) (K Units)
Table 59. Latin America Humira Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Humira Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Humira Revenue Market Share by Country (2015-2020)
Table 62. Latin America Humira Sales by Type (2015-2020) (K Units)
Table 63. Latin America Humira Sales Market Share by Type (2015-2020)
Table 64. Latin America Humira Sales by Application (2015-2020) (K Units)
Table 65. Latin America Humira Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Humira Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Humira Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Humira Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Humira Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Humira Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Humira Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Humira Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Humira Sales Market Share by Application (2015-2020)
Table 74. AbbVie Corporation Information
Table 75. AbbVie Description and Major Businesses
Table 76. AbbVie Humira Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. AbbVie Product
Table 78. AbbVie Recent Development
Table 79. Eisai Corporation Information
Table 80. Eisai Description and Major Businesses
Table 81. Eisai Humira Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Eisai Product
Table 83. Eisai Recent Development
Table 84. Cadila Healthcare Corporation Information
Table 85. Cadila Healthcare Description and Major Businesses
Table 86. Cadila Healthcare Humira Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Cadila Healthcare Product
Table 88. Cadila Healthcare Recent Development
Table 89. Torrent Pharmaceuticals Corporation Information
Table 90. Torrent Pharmaceuticals Description and Major Businesses
Table 91. Torrent Pharmaceuticals Humira Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Torrent Pharmaceuticals Product
Table 93. Torrent Pharmaceuticals Recent Development
Table 94. Amgen Corporation Information
Table 95. Amgen Description and Major Businesses
Table 96. Amgen Humira Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Amgen Product
Table 98. Amgen Recent Development
Table 99. Boehringer Ingelheim Corporation Information
Table 100. Boehringer Ingelheim Description and Major Businesses
Table 101. Boehringer Ingelheim Humira Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Boehringer Ingelheim Product
Table 103. Boehringer Ingelheim Recent Development
Table 104. Global Humira Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Humira Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Humira Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Humira Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Humira Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Humira Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Humira Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Humira Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Humira Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Humira Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Humira Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Humira Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Humira Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Humira Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Humira Players
Table 122. Humira Customers List
Table 123. Humira Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Humira Product Picture
Figure 2. Global Humira Sales Market Share by Type in 2020 & 2026
Figure 3. Humira Syringe Product Picture
Figure 4. Humira Pen Product Picture
Figure 5. Global Humira Sales Market Share by Application in 2020 & 2026
Figure 6. Ankylosing Spondylitis
Figure 7. Rheumatoid Arthritis
Figure 8. Crohn’s Disease
Figure 9. Other
Figure 10. Humira Report Years Considered
Figure 11. Global Humira Market Size 2015-2026 (US$ Million)
Figure 12. Global Humira Sales 2015-2026 (K Units)
Figure 13. Global Humira Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Humira Sales Market Share by Region (2015-2020)
Figure 15. Global Humira Sales Market Share by Region in 2019
Figure 16. Global Humira Revenue Market Share by Region (2015-2020)
Figure 17. Global Humira Revenue Market Share by Region in 2019
Figure 18. Global Humira Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Humira Revenue in 2019
Figure 20. Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Humira Sales Market Share by Type (2015-2020)
Figure 22. Global Humira Sales Market Share by Type in 2019
Figure 23. Global Humira Revenue Market Share by Type (2015-2020)
Figure 24. Global Humira Revenue Market Share by Type in 2019
Figure 25. Global Humira Market Share by Price Range (2015-2020)
Figure 26. Global Humira Sales Market Share by Application (2015-2020)
Figure 27. Global Humira Sales Market Share by Application in 2019
Figure 28. Global Humira Revenue Market Share by Application (2015-2020)
Figure 29. Global Humira Revenue Market Share by Application in 2019
Figure 30. North America Humira Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Humira Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Humira Sales Market Share by Country in 2019
Figure 33. North America Humira Revenue Market Share by Country in 2019
Figure 34. U.S. Humira Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Humira Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Humira Market Share by Type in 2019
Figure 39. North America Humira Market Share by Application in 2019
Figure 40. Europe Humira Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Humira Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Humira Sales Market Share by Country in 2019
Figure 43. Europe Humira Revenue Market Share by Country in 2019
Figure 44. Germany Humira Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Humira Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Humira Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Humira Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Humira Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Humira Market Share by Type in 2019
Figure 55. Europe Humira Market Share by Application in 2019
Figure 56. Asia Pacific Humira Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Humira Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Humira Sales Market Share by Region in 2019
Figure 59. Asia Pacific Humira Revenue Market Share by Region in 2019
Figure 60. China Humira Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Humira Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Humira Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Humira Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Humira Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Humira Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Humira Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Humira Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Humira Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Humira Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Humira Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Humira Market Share by Type in 2019
Figure 83. Asia Pacific Humira Market Share by Application in 2019
Figure 84. Latin America Humira Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Humira Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Humira Sales Market Share by Country in 2019
Figure 87. Latin America Humira Revenue Market Share by Country in 2019
Figure 88. Mexico Humira Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Humira Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Humira Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Humira Market Share by Type in 2019
Figure 95. Latin America Humira Market Share by Application in 2019
Figure 96. Middle East and Africa Humira Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Humira Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Humira Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Humira Revenue Market Share by Country in 2019
Figure 100. Turkey Humira Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Humira Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Humira Sales Growth Rate (2015-2020) (K Units)
Figure 105. UAE Humira Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Humira Market Share by Type in 2019
Figure 107. Middle East and Africa Humira Market Share by Application in 2019
Figure 108. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Cadila Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Torrent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Humira Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America Humira Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Humira Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe Humira Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Humira Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific Humira Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Humira Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America Humira Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Humira Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa Humira Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed


More Publications